Sai Life Sciences’ API Manufacturing unit receives ‘CII Excellent Energy Efficient Unit’ award
Sai Life Sciences, a global CRO & CDMO offering sustainable solutions to pharmaceutical companies through strategic partnerships and integrated drug discovery and development services, has been awarded with ‘Excellent Energy Efficient Unit’ in the general category at CII’s 22nd National Energy Management Awards.
This is the second consecutive year that Sai Life Sciences’ Bidar API manufacturing unit has been awarded by CII for its energy management.
Sai Life Sciences, a global CRO & CDMO offering sustainable solutions to pharmaceutical companies through strategic partnerships and integrated drug discovery and development services, has been awarded with ‘Excellent Energy Efficient Unit’
in the general category at CII’s 22nd National Energy Management
Awards. This is the second consecutive year that Sai Life Sciences’
Bidar API manufacturing unit has been awarded by CII for its energy management.
Congratulating the team, Krishna Kanumuri, CEO & Managing Director said, ‘’The
consistency of our performance in energy conservation and
sustainability parameters in the past two years speaks volumes on the
commitment of our engineers and utility managers who are relentless in
their focus and consistently come up with innovative solutions to take
us closer to our sustainable development goals.”
The 22nd edition of National Award for Excellence in
Energy Management is a flagship event of Confederation of Indian
Industries (CII) with the objective to recognize and award excellence in
energy management and facilitate the sharing of information on best
practices and technologies. CII’s National Energy Award is the best
platform for the organizations that have made outstanding contributions
in energy efficiency to showcase their efforts and achievements.
The Bidar API manufacturing facility of Sai Life Sciences has been on
a path of significant expansion with its production capacity growing
from 200KL in 2017 to 450KL today and on course to be 600KL in 2022.
Along the way it has ensured a steadfast commitment to safer, compliant
and sustainable manufacturing practices.
Key energy conservation performance indicators of the site FY21
The following improvements in the site’s energy performance were
achieved while sustaining a significant increase in the overall
production of finished goods YoY:
Energy cost reduction
- 10% drop in thermal cost
- 5% drop in electrical cost
Energy consumption reduction
- 7.7% drop in thermal consumption
- 5.5% drop in electrical consumption
Specific Energy Consumption (SEC)
- 19% reduced w.r.t MTOE/ Ton of FG
Energy conservation projects (energy saving)
- FY20: 0.40 million kWh units/annum (Rs.3.03 million/ year)
- FY21: 1.33 million kWh units/annum (Rs.9.64 million/ year)
CO2 Emissions
- FY20: 338 Tons CO2 / ton FG
- FY21: 210 Tons CO2 / ton FG (37 % drop compared to FY20)
Renewable Energy Adoption
- FY 2020: 21%
- FY 2021: 53%
The recognition of Bidar manufacturing unit has followed the recent milestone of Sai Life Sciences becoming a signatory of United Nations Global Compact and receiving a 5-star rating for excellence in EHS practices at the 13th edition of the Confederation of Indian Industry’s (CII-SR) EHS Excellence Awards.
Related News
-
Sponsored Content CPHI Online Trend Report: How can flow chemistry help businesses achieve their sustainability goals?
In our latest CPHI Online Trend Report, we partner with Asymchem to understand the innovative potential of flow chemistry for API manufacturing, especially in regards to meeting sustainability goals. -
Sponsored Content Ashwagandha and Herbal Medicines: Pharma’s Next Opportunity
Herbal medicines and nutraceuticals have seen a surge in interest since the onset of the COVID-19 pandemic. Driven by patient interest in prioritising personalised and integrative medicines, the herbal ingredients industry is now faced with concerns pe... -
Sponsored Content Discover Our Organic Mineral Salts as APIs
Discover the range of organic mineral salts that serve as Active Pharmaceutical Ingredients available from Dr. Paul Lohmann®. -
Sponsored Content CPHI Podcast Series: Ursatec – celebrating 30 years of pioneering preservative free
In the latest episode of the CPHI Podcast Series, Digital Editor Lucy Chard spoke with Dominik Rocchi of Ursatec. -
Sponsored Content How healthcare trends inform dosage forms
Capsules encompass one of the most popular solid oral dosage forms for pharmaceutical products, with the global empty capsule market predicted to rise to USD $3.7 billion by 2026. The growth in the capsule market can be partly attributed to the many op... -
Sponsored Content Pharma Trend Outlook: Pharma 4.0 and Industry Resilience
Download our 2023 Pharma Trends Outlook report to discover the trends set to shape the pharmaceutical landscape in the new year, with expert opinions and insight from across the pharmaceutical value chain. -
Sponsored Content CPHI Podcast Series: Key Considerations in Selecting the Right CMO Partner
In this month's episode we hear from Jayna Blake, Senior Project Manager for Technical Programs at Baxter BioPharma Solutions, on key considerations for successful CMO selection. -
Sponsored Content Size doesn’t matter: How smaller deals are shaping healthcare M&A
Several mega-deals have made a splash in the pharma and life sciences industries over recent years – from AstraZeneca’s acquisition of Alexion for $39 billion to Gilead Sciences’ $21 billion purchase of Immunomedics. With am...
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance